ClinicalTrials.gg
Not yet recruitingNCT07820904Updated Sep 15, 2026

THE EFFECT OF 360° VIDEO-ASSISTED TRAINING ON VERTICAL BIRTH POSITIONS IN PRIMIPAROUS WOMEN ON FEAR OF CHILDBIRTH, SELF-EFFICACY IN CHILDBIRTH, SATISFACTION WITH CHILDBIRTH, AND PERINEAL TRAUMA: A RANDOMIZED CONTROLLED TRIAL

An interventional study of 360° Video-Supported Upright Birth Positions Education in Childbirth, sponsored by Bitlis Eren University. Not yet recruiting at 1 site in Turkey (Türkiye). Open to female participants. Per ClinicalTrials.gov, last updated 2026-09-15.

Sponsored by Bitlis Eren University · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
92
Allocation
Randomized
Sex
Female
01

Study summary

This randomized controlled trial aims to evaluate the effects of 360-degree video-supported upright birth position education on fear of childbirth, childbirth self-efficacy, birth satisfaction, and perineal trauma among primiparous pregnant women. Eligible participants will be randomly assigned to one of three intervention groups or a control group. In addition to routine antenatal care, participants in the intervention groups will receive 360-degree video-supported education on one of three upright birth positions: use of a Pilates ball, birth dance, or squatting. Participants in the control group will receive routine antenatal care only.

The study will examine whether 360-degree video-supported education can help primiparous women prepare for childbirth, reduce fear of childbirth, improve childbirth self-efficacy and birth satisfaction, and reduce the occurrence of perineal trauma. The outcomes of the three intervention groups will also be explored to determine whether the effects differ according to the type of upright birth position.

02

Conditions studied

  • Childbirth

Keywords

  • primiparous pregnancy, childbirth fear, childbirth self-efficacy, birth satisfaction, perineal trauma, 360-degree video
03

In context

Lead sponsor

Bitlis Eren University is the lead sponsor of 51 studies on the registry; 17 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Having signed the Form.
  • Being able to speak and understand Turkish.
  • Being literate.
  • Having no impairment that would interfere with auditory, visual, or cognitive communication.
  • Being primiparous.
  • Having a singleton live fetus.
  • Being between 28 and 32 weeks of gestation.
  • Having a fetus in cephalic presentation.
  • Planning a vaginal birth.
  • Being enrolled and randomized before the onset of labor.
  • Being able to use a smartphone or tablet.
  • Having sufficient physical and cognitive ability to watch the 360° video education.
  • Having moderate fear of childbirth, defined as a score of 38 or higher on the W-DEQ-A.

Exclusion criteria

Exclusion Criteria:

  • Refusal to participate in the study or withdrawal from the study.
  • Development of a serious maternal or fetal complication during labor that prevents continuation of the study intervention.
  • Giving birth by elective or emergency cesarean section.
  • Loss of study data during the research process.
  • Giving birth outside Bitlis State Hospital.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
92 participants (estimated)

Study arms

  • Experimental
    Pilates Ball Group

    Participants will receive 360° video-supported education on upright birth positions using a Pilates ball.

    Behavioral: 360° Video-Supported Upright Birth Positions Education

  • Experimental
    Birth Dance Group

    Participants will receive 360° video-supported education on upright birth positions using birth dance.

    Behavioral: 360° Video-Supported Upright Birth Positions Education

  • Experimental
    Squatting Group

    Participants will receive 360° video-supported education on upright birth positions using supported squatting.

    Behavioral: 360° Video-Supported Upright Birth Positions Education

  • No intervention
    Control Group

    Participants will receive routine antenatal care without the 360° video-supported upright birth positions education during the study period.

Interventions

  • Behavioral360° Video-Supported Upright Birth Positions Education

    Participants will receive standardized 360° video-supported education on upright birth positions. The education will include Pilates ball exercises, birth dance, and supported squatting techniques. Each video will demonstrate the relevant birth position and provide information on its proper use, body movements, weight transfer, and position changes. Each video will be approximately 12 minutes (±30 seconds) in duration and will be viewed using a smartphone or tablet.

06

What researchers measure

Primary outcomes

  1. Change in Childbirth Fear Score

    Childbirth fear will be assessed using the Wijma Delivery Expectancy/Experience Questionnaire-A (W-DEQ-A) before randomization and the W-DEQ-B after childbirth. The change in childbirth fear score will be compared between the study groups.

    Time frame: From baseline (before randomization) to 24-48 hours after childbirth

Secondary outcomes

  1. Change in Childbirth Self-Efficacy Score

    Childbirth self-efficacy will be assessed using the Childbirth Self-Efficacy Scale before randomization and within 24-48 hours after childbirth. The change in score will be compared between the study groups.

    Time frame: From baseline (before randomization) to 24-48 hours after childbirth

  2. Birth Satisfaction Score

    Birth satisfaction will be assessed using the Birth Satisfaction Scale Short Form within 24-48 hours after childbirth.

    Time frame: Within 24-48 hours after childbirth

  3. Perineal Trauma

    Perineal trauma will be assessed immediately after childbirth during routine clinical evaluation and classified according to the Sultan classification as intact perineum, episiotomy, or first-, second-, third-, or fourth-degree perineal laceration.

    Time frame: Immediately after childbirth

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Oct 2026; primary completion for Feb 2027, 4 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 10, 2026
First posted
Sep 15, 2026
StartEst.
Oct 1, 2026
Primary completionEst.
Feb 28, 2027
CompletionEst.
Mar 1, 2027
Last update
Sep 15, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 15, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07820904
Lead sponsor
Bitlis Eren University
Responsible party
Rozerin BALCI (Lecturer, Department of Midwifery, Bitlis Eren University) — Principal investigator
First posted
Sep 15, 2026
Start date
Oct 1, 2026 (estimated)
Primary completion
Feb 28, 2027 (estimated)
Completion
Mar 1, 2027 (estimated)
Last update
Sep 15, 2026

Study contacts

Rozerin Balcı
Contact
rbalci@beu.edu.tr
+905398339950

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion